Cite
HARVARD Citation
Martins-Neves, S. et al. (2018). IWR-1, a tankyrase inhibitor, attenuates Wnt/β-catenin signaling in cancer stem-like cells and inhibits in vivo the growth of a subcutaneous human osteosarcoma xenograft. Cancer letters. pp. 1-15. [Online].